Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -174,325 | -124,697 | -96,015 | -85,981 | -72,188 |
| Depreciation Amortization | -238 | -1,137 | 173 | 2,641 | 4,081 |
| Accounts receivable | N/A | N/A | N/A | 110 | -110 |
| Accounts payable and accrued liabilities | -1,093 | 2,205 | -764 | -5,246 | 1,209 |
| Other Working Capital | -6,822 | 2,850 | -8,868 | -3,689 | -23,041 |
| Other Operating Activity | 26,189 | 20,767 | 11,294 | -5,812 | 12,285 |
| Operating Cash Flow | $-156,289 | $-100,012 | $-94,180 | $-97,977 | $-77,764 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -57,386 | -15,437 | 11,204 | 30,049 | -89,805 |
| PPE Investments | -1,068 | -649 | -1,515 | -2,415 | -1,281 |
| Net Acquisitions | N/A | N/A | N/A | 31,523 | N/A |
| Investing Cash Flow | $-58,454 | $-16,086 | $9,689 | $59,157 | $-91,086 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,143 | N/A |
| Debt Repayment | -723 | -473 | N/A | N/A | N/A |
| Common Stock Issued | 196,425 | 127,684 | 2,974 | 72,573 | 134,919 |
| Other Financing Activity | -1,256 | -4,774 | 148 | 115 | 66 |
| Financing Cash Flow | $194,446 | $122,437 | $3,122 | $74,831 | $134,985 |
| Beginning Cash Position | 82,187 | 75,848 | 157,217 | 121,206 | 155,071 |
| End Cash Position | 61,890 | 82,187 | 75,848 | 157,217 | 121,206 |
| Net Cash Flow | $-20,297 | $6,339 | $-81,369 | $36,011 | $-33,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | -156,289 | -100,012 | -94,180 | -97,977 | -77,764 |
| Capital Expenditure | -1,153 | -654 | -1,515 | -3,015 | -1,281 |
| Free Cash Flow | -157,442 | -100,666 | -95,695 | -100,992 | -79,045 |